Docosahexaenoic acid suppresses the expression of FoxO and its target genes

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1609-1616

  Chen, Yu Jen ^a   Chen, Chih Chien ^a   Li, Tsai Kun ^a,b   Wang, Pei Hwa ^a   Liu, Li Ru ^a   Chang, Fang Ying ^a   Wang, Ya Chin ^a   Yu, Yu Hsiang ^a   Lin, Shau Ping ^a   Mersmann, Harry J ^a   Ding, Shih Torng ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Docosahexaenoic acid (DHA); Forkhead box O transcription factor (FoxO); Lipid glucose homeostasis; Pigs

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; DOCOSAHEXAENOIC ACID; GLUCOSE 6 PHOSPHATASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOYBEAN OIL; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEEF; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; EXPERIMENTAL PIG; FEMALE; GENE EXPRESSION; GENE TARGETING; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLESTEROL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LIPID METABOLISM; LIVER; LIVER NEOPLASMS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SWINE; TRIGLYCERIDES;

GLYCINE MAX; SUIDAE; SUS;

EID: 84869081008     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.11.003     Document Type: Article

References (56)

1. Zittermann A., Frisch S., Berthold H.K., Gotting C., Kuhn J., Kleesiek K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89:1321-1327.
2. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
3. Barish G.D., Narkar V.A., Evans R.M. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 2006, 116:590-597.
4. Raclot T., Groscolas R. Individual fish-oil n-3 polyunsaturated fatty acid deposition and mobilization rates for adipose tissue of rats in a nutritional steady state. Am J Clin Nutr 1994, 60:72-78.
5. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chugh S.S., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005, 293:2884-2891.
6. Hsu J.M., Wang P.H., Liu B.H., Ding S.T. The effect of dietary docosahexaenoic acid on the expression of porcine lipid metabolism-related genes. J Anim Sci 2004, 82:683-689.
7. Liu B.H., Wang Y.C., Kuo C.F., Cheng W.M., Shen T.F., Ding S.T. The effects of docosahexaenoic acid oil and soybean oil on the expression of lipid metabolism related mRNA in pigs. Asian-Australasian Journal of Animal Sciences 2005, 18:1451-1456.
8. Yahagi N., Shimano H., Hasty A.H., Amemiya-Kudo M., Okazaki H., Tamura Y., et al. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J Biol Chem 1999, 274:35840-35844.
9. Xu J., Nakamura M.T., Cho H.P., Clarke S.D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J Biol Chem 1999, 274:23577-23583.
10. Myatt S.S., Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007, 7:847-859.
11. Birkenkamp K.U., Coffer P.J. FOXO transcription factors as regulators of immune homeostasis: molecules to die for?. J Immunol 2003, 171:1623-1629.
12. van der Horst A., Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007, 8:440-450.
13. Maiese K., Chong Z.Z., Shang Y.C. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med 2008, 14:219-227.
14. Biggs W.H., Cavenee W.K., Arden K.C. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm Genome 2001, 12:416-425.
15. Nakae J., Oki M., Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett 2008, 582:54-67.
16. Tai C.C., Chen C.Y., Lee H.S., Wang Y.C., Li T.K., Mersamm H.J., et al. Docosahexaenoic acid enhances hepatic serum amyloid A expression via protein kinase A-dependent mechanism. J Biol Chem 2009, 284:32239-32247.
17. Tseng Y.W., Wang P.H., Lee H.S., Liu B.H., Mersmann H.J., Lin E.C., et al. Regulation of the expression of angiotensin-converting enzyme 2 by polyunsaturated fatty acids in porcine adipocytes. J Anim Sci 2010, 88:3563-3567.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
20. Raclot T., Groscolas R., Langin D., Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 1997, 38:1963-1972.
21. Hannah V.C., Ou J., Luong A., Goldstein J.L., Brown M.S. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem 2001, 276:4365-4372.
22. Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 2001, 98:6027-6032.
23. Dentin R., Benhamed F., Pegorier J.P., Foufelle F., Viollet B., Vaulont S., et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 2005, 115:2843-2854.
24. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A 1993, 90:2160-2164.
25. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 1997, 94:4318-4323.
26. Yoshikawa T., Shimano H., Yahagi N., Ide T., Amemiya-Kudo M., Matsuzaka T., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002, 277:1705-1711.
27. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
28. Rajas F., Gautier A., Bady I., Montano S., Mithieux G. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha. J Biol Chem 2002, 277:15736-15744.
29. Liu B.H., Kuo C.F., Wang Y.C., Ding S.T. Effect of docosahexaenoic acid and arachidonic acid on the expression of adipocyte determination and differentiation-dependent factor 1 in differentiating porcine adipocytes. J Anim Sci 2005, 83:1516-1525.
30. Furuyama T., Nakazawa T., Nakano I., Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 2000, 349:629-634.
31. O'Brien R.M., Granner D.K. Regulation of gene expression by insulin. Physiol Rev 1996, 76:1109-1161.
32. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 2006, 281:10105-10117.
33. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002, 32:245-253.
34. Antrasferry J., Robin P., Robin D., Forest C. Fatty-acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes. Eur J Biochem 1995, 234:390-396.
35. Neschen S., Morino K., Rossbacher J.C., Pongratz R.L., Cline G.W., Sono S., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 2006, 55:924-928.
36. Altomonte J., Cong L., Harbaran S., Richter A., Xu J., Meseck M., et al. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest 2004, 114:1493-1503.
37. Kamagate A., Qu S., Perdomo G., Su D., Kim D.H., Slusher S., et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 2008, 118:2347-2364.
38. Pollin T.I., Damcott C.M., Shen H., Ott S.H., Shelton J., Horenstein R.B., et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008, 322:1702-1705.
39. Olivieri O., Martinelli N., Sandri M., Bassi A., Guarini P., Trabetti E., et al. Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction. Clin Chem 2005, 51:360-367.
40. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003, 4:119-129.
41. Dowell P., Otto T.C., Adi S., Lane M.D. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. J Biol Chem 2003, 278:45485-45491.
42. Armoni M., Harel C., Karni S., Chen H., Bar-Yoseph F., Ver M.R., et al. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J Biol Chem 2006, 281:19881-19891.
43. Yu Y.H., Lin E.C., Wu S.C., Cheng W.T., Mersmann H.J., Wang P.H., et al. Docosahexaenoic acid regulates adipogenic genes in myoblasts via porcine peroxisome proliferator-activated receptor gamma. J Anim Sci 2008, 86:3385-3392.
44. Yu Y.H., Wu S.C., Cheng W.T., Mersmann H.J., Shen T.L., Ding S.T. The function of porcine PPARgamma and dietary fish oil effect on the expression of lipid and glucose metabolism related genes. J Nutr Biochem 2011, 22:179-186.
45. Moller D.E., Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005, 56:45-62.
46. Consoli A., Nurjhan N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989, 38:550-557.
47. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
48. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40:280-289.
49. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998, 21:494-500.
50. Podolin D.A., Gayles E.C., Wei Y.R., Thresher J.S., Pagliassotti M.J. Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats. Am J Physiol Regul Integr Comp Physiol 1998, 43:R840-R848.
51. Herzberg G.R., Rogerson M. Hepatic fatty acid synthesis and triglyceride secretion in rats fed fructose- or glucose-based diets containing corn oil, tallow or marine oil. J Nutr 1988, 118:1061-1067.
52. Puglisi M.J., Hasty A.H., Saraswathi V. The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem 2011, 22:101-108.
53. Wang Y.C., Kuo W.H., Chen C.Y., Lin H.Y., Wu H.T., Liu B.H., et al. Docosahexaenoic acid regulates serum amyloid A protein to promote lipolysis through down regulation of perilipin. J Nutr Biochem 2010, 21:317-324.
54. Samuel V.T., Choi C.S., Phillips T.G., Romanelli A.J., Geisler J.G., Bhanot S., et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 2006, 55:2042-2050.
55. Kim J.J., Li P., Huntley J., Chang J.P., Arden K.C., Olefsky J.M. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue. Diabetes 2009, 58:1275-1282.
56. Nagashima T., Shigematsu N., Maruki R., Urano Y., Tanaka H., Shimaya A., et al. Discovery of novel forkhead box o1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol 2010, 78:961-970.